270 related articles for article (PubMed ID: 21835562)
1. A survey study to characterize use of Spice products (synthetic cannabinoids).
Vandrey R; Dunn KE; Fry JA; Girling ER
Drug Alcohol Depend; 2012 Jan; 120(1-3):238-41. PubMed ID: 21835562
[TBL] [Abstract][Full Text] [Related]
2. Spicing things up: synthetic cannabinoids.
Spaderna M; Addy PH; D'Souza DC
Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
[TBL] [Abstract][Full Text] [Related]
3. [Spice drugs: cannabinoids as a new designer drugs].
Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
[TBL] [Abstract][Full Text] [Related]
4. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
Seely KA; Lapoint J; Moran JH; Fattore L
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
[TBL] [Abstract][Full Text] [Related]
5. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
Brents LK; Prather PL
Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
[TBL] [Abstract][Full Text] [Related]
6. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
7. Using Web searches to track interest in synthetic cannabinoids (a/k/a 'herbal incense').
Curtis B; Alanis-Hirsch K; Kaynak Ö; Cacciola J; Meyers K; McLellan AT
Drug Alcohol Rev; 2015 Jan; 34(1):105-8. PubMed ID: 25196534
[TBL] [Abstract][Full Text] [Related]
8. A survey of synthetic cannabinoid consumption by current cannabis users.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
[TBL] [Abstract][Full Text] [Related]
9. The Synthetic Cannabinoids Phenomenon.
Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
[TBL] [Abstract][Full Text] [Related]
10. Beyond THC: The New Generation of Cannabinoid Designer Drugs.
Fattore L; Fratta W
Front Behav Neurosci; 2011; 5():60. PubMed ID: 22007163
[TBL] [Abstract][Full Text] [Related]
11. [Effect and occurrence of synthetic cannabinoids].
Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
[TBL] [Abstract][Full Text] [Related]
12. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
[TBL] [Abstract][Full Text] [Related]
13. Spice, vulnerability, and victimization: Synthetic cannabinoids and interpersonal crime victimization among homeless adults.
Ellsworth JT
Subst Abus; 2022; 43(1):32-38. PubMed ID: 31697191
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".
Zimmermann US; Winkelmann PR; Pilhatsch M; Nees JA; Spanagel R; Schulz K
Dtsch Arztebl Int; 2009 Jul; 106(27):464-7. PubMed ID: 19652769
[TBL] [Abstract][Full Text] [Related]
15. Spice drugs as a new trend: mode of action, identification and legislation.
Vardakou I; Pistos C; Spiliopoulou Ch
Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs of abuse: current perspectives on synthetic cannabinoids.
Debruyne D; Le Boisselier R
Subst Abuse Rehabil; 2015; 6():113-29. PubMed ID: 26543389
[TBL] [Abstract][Full Text] [Related]
17. The behavioral profile of spice and synthetic cannabinoids in humans.
Müller HH; Kornhuber J; Sperling W
Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494
[TBL] [Abstract][Full Text] [Related]
18. Synthetic drugs of abuse.
Tamama K
Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cannabinoids and potential reproductive consequences.
Sun X; Dey SK
Life Sci; 2014 Feb; 97(1):72-7. PubMed ID: 23827241
[TBL] [Abstract][Full Text] [Related]
20. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
